Search results
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 3 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
Amy Dowden congratulated by fellow Strictly stars on ‘deserved’ MBE
Press Association News via AOL· 6 days agoShe was diagnosed with the condition when she was a child. She has recently also said she was...
Digestive Disease Week 2024 - Nature Reviews Gastroenterology & Hepatology
Nature· 5 days agoFrom 18–21 May 2024, Nature Reviews Gastroenterology & Hepatology was back at Digestive Disease Week (DDW) in Washington DC, USA, alongside >14,300 attendees both in person and virtually, according ...
How to Optimize Your Endocrine Health
Mercola· 6 days agoEndocrinology is a branch of medicine that focuses on the study of hormones and the glands and tissues that produce them. Littlewood, who splits his time between consulting with patients and ...
Advice | What the latest science says about Lyme disease
Washington Post· 4 days agoLyme disease is a bacterial infection that spreads through tick bites. It may cause flu-like symptoms and a bull’s-eye-shaped rash. Most people fully recover after a few weeks of antibiotic ...
